Phillips Financial Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
689
-53
-7% -$18.1K 0.02% 177
2026
Q1
$261K Sell
742
-3
-0.4% -$1.07K 0.02% 173
2025
Q4
$244K Sell
745
-17
-2% -$5.39K 0.02% 185
2025
Q3
$215K Sell
762
-6
-0.8% -$1.74K 0.01% 202
2025
Q2
$214K Sell
768
-25
-3% -$7.08K 0.02% 181
2025
Q1
$247K Buy
+793
New +$234K 0.02% 167
2024
Q4
Sell
-705
Closed -$227K 261
2024
Q3
$227K Buy
705
+61
+9% +$20K 0.02% 174
2024
Q2
$201K Buy
+644
New +$189K 0.02% 181

Other funds holding AMGN

Phillips Financial Management's AMGN Position: Q2 2026 in Review

Phillips Financial Management reduced its Amgen (AMGN) stake by 7.1% in Q2 2026, selling an estimated $18.1K and leaving 689 shares worth $250K. The position accounts for 0.02% of the portfolio, ranked #177.

Phillips Financial Management first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $261K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Phillips Financial Management held 689 shares of Amgen worth $250K as of Q2 2026.
  • Phillips Financial Management sold 53 Amgen shares in Q2 2026, an estimated $18.1K.
  • Amgen made up 0.02% of Phillips Financial Management's portfolio in Q2 2026, its #177 holding.
  • Phillips Financial Management first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • Phillips Financial Management's Amgen position peaked at $261K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Phillips Financial Management's 13F filing for Q2 2026, filed 3 Aug 2026.